Initiative Increased BRCA Testing in Ovarian Cancer Patients
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
The risk of cancer remains high for women older than 50 years with BRCA1 or BRCA2 mutations, a study suggests.
Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, a study suggests.
Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures.
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
More patients should consider having their fallopian tubes removed to prevent ovarian cancer, according to the Ovarian Cancer Research Alliance.
Purchases of over-the-counter pain and indigestion medications could be used to predict ovarian cancer months before diagnosis, a study suggests.
Compared with the general population, survivors of gynecologic cancers have a higher risk of sexual dysfunction 1 to 5 years after cancer diagnosis.
Non-Hispanic Black patients are less likely than Hispanic or non-Hispanic White patients to receive guideline-recommended treatment for ovarian cancer.